» Articles » PMID: 1383414

A Microtitre Format Point Mutation Assay: Application to the Detection of Drug Resistance in Human Immunodeficiency Virus Type-1 Infected Patients Treated with Zidovudine

Overview
Journal J Med Virol
Specialty Microbiology
Date 1992 Aug 1
PMID 1383414
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

An assay for the analysis of point mutations in DNA fragments amplified by the polymerase chain reaction is described. The method was applied to the analysis of mutations leading to single amino acid changes in the reverse transcriptase gene of human immunodeficiency virus type-1 that are associated with decreased sensitivity of the virus to the effects of the nucleoside analogue zidovudine. The assay uses a microtitre format allowing large numbers of clinical samples to be analysed, and is a quantitative assay giving information on the relative proportions of wild-type and mutant sequence at the point being analysed. The analysis of mutations in codons 67, 70, 215, and 219 of the RT gene in samples taken at various time points after the commencement of zidovudine therapy shows a high variability in the rate at which these mutations arise and in the proportions of wild-type and mutant sequences observed. The method we describe has wide application to the analysis of other point mutations in clinical or research studies.

Citing Articles

Biosensors for Point Mutation Detection.

Jiang H, Xi H, Juhas M, Zhang Y Front Bioeng Biotechnol. 2022; 9:797831.

PMID: 34976987 PMC: 8714947. DOI: 10.3389/fbioe.2021.797831.


Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Kapoor A, Jones M, Shafer R, Rhee S, Kazanjian P, Delwart E J Virol. 2004; 78(13):7112-23.

PMID: 15194787 PMC: 421662. DOI: 10.1128/JVI.78.13.7112-7123.2004.


Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial.

Arch Dis Child. 2001; 84(3):230-6.

PMID: 11207172 PMC: 1718689. DOI: 10.1136/adc.84.3.230.


Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection.

Frost S, Nijhuis M, Schuurman R, Boucher C, Brown A J Virol. 2000; 74(14):6262-8.

PMID: 10864635 PMC: 112131. DOI: 10.1128/jvi.74.14.6262-6268.2000.


Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.

Schuurman R, Demeter L, Reichelderfer P, Tijnagel J, de Groot T, Boucher C J Clin Microbiol. 1999; 37(7):2291-6.

PMID: 10364600 PMC: 85140. DOI: 10.1128/JCM.37.7.2291-2296.1999.